Editorial: on the road towards treatment of gastroparesis-accelerating, but do we get closer? Authors' reply.
Phase I study of emactuzumab single agent or in combination with paclitaxel in patients with advanced/metastatic solid tumors reveals depletion of immunosuppressive M2-like macrophages.
Extending i2b2 into a framework for semantic abstraction of EHR to facilitate rapid development and portability of Health IT applications.
